CinCor Pharma competitorsClear all

Xenikos's top competitors include Allakos, Nocion Therapeutics and Meissa Vaccines.
Xenikos
Xenikos
Xenikos is a clinical-stage biopharmaceutical company.
Allakos
Allakos
Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.
Nocion Therapeutics
Nocion Therapeutics
Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons.
Meissa Vaccines
Meissa Vaccines
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
Founding Date
Founding Date
2012
Founding Date
2012
Founding Date
2018
Founding Date
2014
Type
Type
Private
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Nijmegen, NL HQ
Locations
Redwood City, US HQ
Locations
Waltham, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
13
Employees
967% increase
Employees
3
Employees
16
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
515894
Alexa Website Rank
311721
Alexa Website Rank
374468

Funding

Latest funding round
Latest funding round
$ 30m (over 2 years ago)
Latest funding round
N/A
Latest funding round
$ 27m (almost 2 years ago)
Latest funding round
$ 30m (over 1 year ago)
Total funding raised
Total funding raised
$ 37m
Total funding raised
N/A
Total funding raised
$ 27m
Total funding raised
$ 33.4m
For sources of this data, please see the company profile

View company profiles

Allakos
HQ
Redwood City, US
Employees
96↑ 7% increase

Allakos, a biopharmaceutical company, focuses on developing therapeutic antibodies targeting allergic, inflammatory, and proliferative diseases.

View company
Nocion Therapeutics
HQ
Waltham, US
Employees
3

Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons.

View company
Meissa Vaccines
HQ
South San Francisco, US
Employees
16

Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.

View company